Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFocusrite Regulatory News (TUNE)

Share Price Information for Focusrite (TUNE)

Share Price is delayed by 15 minutes
Get Live Data
195.00    10.00 (5.41%)
Bid:
190.00
Ask:
200.00
Spread: 10.00 (5.263%)
Market Cap: £113.24m
TUNE Live PriceLast checked at - London Stock Exchange

Intraday Focusrite Share Chart

Board Changes

2 Mar 2026 07:00

RNS Number : 8116U
Focusrite PLC
02 March 2026
 

Strictly embargoed: 07:00, 2 March 2026

 

Focusrite plc

 

("Focusrite", "the Group", or "the Company")

 

Board Changes

Focusrite plc (AIM: TUNE) is pleased to announce that Ian Barkshire has been appointed as an Independent Non-Executive Director and Chair Designate of the Company with immediate effect.

Subject to shareholder approval, Ian will succeed Philip Dudderidge OBE, the founder and current Chair, as Non-Executive Chair following the conclusion of the Company's forthcoming Annual General Meeting, anticipated to be held in July 2026.

As part of this planned transition, Philip Dudderidge will remain on the Board as a Non-Executive Director working closely with Ian to ensure a smooth transition of Board leadership. The Board believes Ian's appointment reflects the Company's continued development and evolution as a global music and audio group while retaining the benefit of Philip's extensive industry knowledge and insights.

Ian was the CEO of Oxford Instruments plc between 2016 and 2023. He spent over 25 years at the business in a number of leadership positions including Chief Operating Officer and Group Technical Director.

Ian brings significant commercial, leadership and public company experience having spent most of his career driving the development, commercialisation and delivery of innovative technologies and specialised products to the world's leading industrial companies. During his tenure as CEO of Oxford Instruments plc, Ian oversaw significant value creation, with an increase in the business's market capitalisation of more than three times.

Earlier in his career, Ian was a Senior Principal Scientist at GEC-Marconi Materials and a Research Fellow at the University of York. He is a Fellow of the Royal Academy of Engineering.

Ian is currently a Non-Executive Director of Melrose Industries PLC. He is also a member of the Strategic Advisory Board of the UK National Quantum Technologies Programme and Chair of Illumion Limited, a University of Cambridge start-up company.

It is intended that Ian will join the Audit, Nominations and Remuneration Committees following his appointment as a director.

The Company also confirms that David Bezem, Senior Independent Director and Chair of the Nomination Committee, has advised the Board that he will not be standing for re-election at the forthcoming AGM. The Board thanks David for his valuable contribution and service during his tenure since the Company's IPO in December 2014.

Philip Dudderidge OBE, Founder and Chair of Focusrite plc, said:

"Focusrite has reached an important stage in its evolution, and I am delighted that Ian has agreed to join our Board as Chair Designate. His experience leading a world class listed technology-driven international business makes him ideally suited to guiding the Board through the next phase of the Group's development. I'm delighted to be remaining as a Non-Executive Director and look forward to supporting Ian and continuing to contribute to Focusrite's future."

"I would also like to thank David personally for his support, insight and commitment during his time on the Board. He has made a substantial contribution to Focusrite's development, and we wish him every success for the future."

Ian Barkshire, Chair Designate, added:

"I'm delighted to be joining the Board of Focusrite plc. The Focusrite Group sits at the heart of the Content Creation and Audio Reproduction industries, with leading brands, a track record of strong product innovation and a passionate global customer base. I look forward to working with my fellow Board members, the executive team and all stakeholders to build on the strong foundations already in place. I'm extremely excited by the future prospects of the Focusrite Group and by the opportunity to help deliver long term growth and shareholder value."

AIM Rule 17 - Schedule Two (g) disclosures

The following information is disclosed in accordance with Schedule Two paragraph (g) of the AIM Rules for Companies:

Current directorships:

· Melrose Industries PLC

· Illumion Limited

· IRB Advisory Limited

Previous directorships held within the last five years:

· Oxford Instruments PLC

· Oxford Instruments Overseas Holdings Limited

· Oxford Instruments Nanotechnology Tools Holdings Limited

· Oxford Instruments Holdings Europe Limited

· Oxford Instruments Uk 2013 Limited

· Oxford Instruments Overseas Holdings 2008 Limited

· Oxford Instruments Industrial Products Holdings Limited

· Oxford Instruments Overseas Marketing Limited

· Andor Technology Limited

· Oxford Instruments AFM Limited

· Oxford Instruments Nanotechnology Tools Limited

· Andor Technology Inc

· Oxford Instruments America, Inc.

Ian Richard Barkshire (60) does not hold any ordinary shares in the Company.

There is no further information required to be disclosed pursuant to Schedule Two paragraph (g) of the AIM Rules.

- ends -

Enquiries:

 

Focusrite plc

+44 (0) 1494 462246

Tim Carroll (CEO) / Sally McKone (CFO)

 

Investec Bank plc (Nominated Adviser and Joint Broker)

+44 (0) 20 7597 5970

David Flin / Nick Prowting / James Smith

 

Rosewood (Financial PR)

 +44 (0) 20 7653 8702

John West / Llewellyn Angus / Lily Pearce

 

 

Notes to Editors

Focusrite plc is a global audio products group that develops and markets proprietary hardware and software products. Used by audio professionals and musicians, its solutions facilitate the high-quality production of recorded and live sound. The Focusrite Group trades under thirteen established brands: Focusrite, Focusrite Pro, Novation, Ampify, ADAM Audio, Martin Audio, Optimal Audio, Linea Research Sequential, Oberheim, Sonnox, OutBoard and TiMax.

With a high-quality reputation and a rich heritage spanning decades, its brands are category leaders in the music-making and audio recording industries. Focusrite and Focusrite Pro offer audio interfaces and other products for recording musicians, producers and professional audio facilities. Novation and Ampify products are used in the creation of electronic music, from synthesizers and grooveboxes to industry-shaping controllers and inspirational music-making apps. ADAM Audio studio monitors have earned a worldwide reputation based on technological innovation in the field of studio loudspeaker technology. Martin Audio designs and manufactures performance-ready systems across the spectrum of sound reinforcement applications. Linea designs, develops, manufactures and sells market innovative professional audio equipment globally. Sequential designs and manufactures high end analogue synthesizers under the Sequential and Oberheim brands. Sonnox is a leading designer of innovative, high-quality, award-winning audio processing software plug-ins for professional audio engineers. TiMax specialises in innovative immersive audio and show control technologies. OutBoard manufactures and sells industry standard rigging control products for live events, together with enterprise-level safety test, preparation and quality management for global rental companies and venues.

The Company has offices in four continents and a global customer base with a distribution network covering approximately 240 territories.

Focusrite plc is traded on the AIM market, London Stock Exchange.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAGCGDDGXDDGLI
Date   Source Headline
9th Mar 20221:25 pmRNSTR-1
1st Mar 20224:42 pmRNSSecond Price Monitoring Extn
1st Mar 20224:36 pmRNSPrice Monitoring Extension
25th Jan 202211:11 amRNSTR-1
17th Dec 202112:27 pmRNSResult of AGM
17th Dec 202110:38 amRNSBoard Changes, Appointment of New NED
17th Dec 20217:00 amRNSAGM Statement and Update on Trading
8th Dec 20211:18 pmRNSNotification of PDMR Transactions
29th Nov 20219:48 amRNSPDMR Dealings
25th Nov 20212:37 pmRNSPDMR Dealings
23rd Nov 20217:00 amRNSTR-1
19th Nov 20214:30 pmRNSGrant of Share Options to PDMRs
19th Nov 20214:25 pmRNSDirector Share Dealings
16th Nov 20217:00 amRNSFinal Results
2nd Nov 20217:00 amRNSNotice of Final Results
13th Oct 20217:00 amRNSChange of adviser
14th Sep 20217:00 amRNSTrading Statement
20th Jul 20217:00 amRNSTrading Statement
14th Jul 20213:56 pmRNSDirector/PDMR Shareholding
18th May 20217:00 amRNSIssue of Management Shares
6th May 20217:00 amRNSPayment of Interim Dividend
4th May 20217:00 amRNSDirector/PDMR Shareholding
27th Apr 20217:01 amRNSHalf Year Results
27th Apr 20217:00 amRNSAcquisition of Sequential LLC
20th Apr 20217:00 amRNSLaunch of New Brand: Optimal Audio
9th Apr 202110:33 amRNSNotice of Interim Results
1st Mar 20217:00 amRNSDirectorate Change
19th Feb 20217:00 amRNSTrading Update
5th Jan 20214:28 pmRNSNotification of PDMR Transactions
24th Dec 20207:00 amRNSShare issuance to EBT
23rd Dec 20206:09 pmRNSTR-1
23rd Dec 202012:08 pmRNSSettlement of Share Options
22nd Dec 20204:07 pmRNSCompletion of Secondary Placing of Shares
22nd Dec 202012:00 pmRNSProposed Secondary Placing of Shares
17th Dec 202012:22 pmRNSResult of 2020 AGM
17th Dec 20207:00 amRNSAGM Statement and Update on Trading
15th Dec 202010:50 amRNSSettlement of Share Options
4th Dec 20202:52 pmRNSSettlement of Share Options
1st Dec 20203:47 pmRNSSettlement of Share Options
25th Nov 20206:02 pmRNSNotification of PDMR Transactions
19th Nov 20203:54 pmRNSDirectors’ Dealings
18th Nov 20201:57 pmRNSDirector Share Dealings
17th Nov 20207:00 amRNSFinal Results for the Year Ended 31 August 2020
4th Nov 20207:00 amRNSNotice of Final Results
14th Sep 20204:40 pmRNSSecond Price Monitoring Extn
14th Sep 20204:35 pmRNSPrice Monitoring Extension
14th Sep 20202:06 pmRNSSecond Price Monitoring Extn
14th Sep 20202:01 pmRNSPrice Monitoring Extension
14th Sep 202011:05 amRNSSecond Price Monitoring Extn
14th Sep 202011:00 amRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.